Evidence map›Paper›PMID 42684056›Full record

ArticleBioinformatics (Oxford, England)2026

COBRA: cell-type-specific orthogonal batch effect removal algorithm in single cell RNA-sequencing data.

Sujin Seo, Sungho Won, Kyungtaek Park

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sujin SeoDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, United States.
Sungho WonDepartment of Public Health Science, Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0000-0001-5751-5089
Kyungtaek ParkDepartment of Statistics, Jeonbuk National University, Jeonju 54896, Republic of Korea.

Funding

Korea governmentNational Research Foundation of Korea
6 · The paper itself

Abstract

motivationSingle-cell RNA sequencing (scRNA-seq) enables high-resolution profiling of cellular heterogeneity, yet batch effects remain a critical challenge in data integration. Existing batch correction methods often assume homogeneous batch effect across cell types, operate in reduced-dimensional space leading to potential loss of biological information, and require extensive computational resources.

resultsHere, we introduce COBRA, a linear model-based batch correction method that explicitly adjusts cell-type-specific batch effect. By orthogonalizing batch-associated parameters with respect to biological variables, COBRA removes technical artifacts while preserving biologically meaningful transcriptional differences. When cell type annotations are unavailable, COBRA implements an iterative clustering algorithm to estimate pseudo-cell types while accounting for batch effects. COBRA retains the full gene expression matrix, ensuring seamless integration for downstream analyses. We evaluated COBRA across simulated and real-world datasets, including type 2 diabetes and COVID-19 datasets. COBRA outperformed in terms of batch mixing efficiency, preservation of biological group structure, and accuracy of differentially expressed gene detection. AVAILABILITY: COBRA is freely available at https://github.com/wonlab-healthstat/COBRA. The code to reproduce the analyses is archived at Zenodo (https://doi.org/10.5281/zenodo.19891355).

Indexed as

AlgorithmsSequence Analysis, RNASingle-Cell AnalysisSoftwareClustering AlgorithmsComputational BiologyGene Expression ProfilingHumansSingle-Cell Gene Expression Analysis

Identifiers

PMID42684056
PMCPMC13612174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.